Prognosis and factors affecting colorectal cancer with ovarian metastasis.
Fangyue ZhouJing-Xin DingPublished in: Updates in surgery (2021)
Colorectal cancer is one of the most common malignant tumors. Its incidence has been increasing in recent years, as has the number of cases of ovarian metastasis of colorectal cancer. The prognosis of colorectal cancer with ovarian metastasis is poor, and it is an important cause of death in female patients. A variety of clinicopathological factors were found to be related to the prognosis of patients with colorectal cancer with ovarian metastasis, such as menopausal status, metastasis limited to the pelvis, and tumor differentiation. Tumor genetic characteristics also provide a new perspective for the prognostic evaluation of colorectal cancer with ovarian metastasis. The prognosis of ovarian metastasis is also closely associated with treatment. The major treatment methods are prophylactic oophorectomy, surgical resection of the primary and metastatic lesions, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy and systematic therapy. If feasible, complete surgical resection of the primary and ovarian metastatic macroscopic lesions combined with postoperative chemotherapy might currently be the most effective treatment for improving the prognosis of patients with colorectal cancer with ovarian metastasis. Genetic analysis also provides a theoretical basis for potential targeted therapy and immunotherapy.
Keyphrases
- small cell lung cancer
- squamous cell carcinoma
- end stage renal disease
- chronic kidney disease
- minimally invasive
- gene expression
- ejection fraction
- risk factors
- dna methylation
- patients undergoing
- radiation therapy
- newly diagnosed
- risk assessment
- replacement therapy
- atrial fibrillation
- percutaneous coronary intervention
- patient reported